Mile 20 and the Screening Gap: When Mass-Participation Marathons Pay With a 25-Year-Old Heart

His wife stood at the roadside at mile 18. She leaned down and kissed her husband. Trey Lara ran on. Two miles later — around mile 20 of the marathon — he collapsed. He was 25, days short of his birthday. His family said he was "completely healthy, with no underlying disease." He had trained for many months before the race, and his motive was not performance: he said he wanted to "relax and relieve stress." The death was reported as "sudden cardiac arrest." Those four words sound like a medical conclusion. In reality, they describe what family members and reporters witnessed, not an autopsy verdict. The gap between the label and the actual biological mechanism is where this article must stand. I have spent 34 years covering sport, most of it looking at women's events, where the question "why" is often pushed aside to make room for the question "how much." But some cases force you to change the axis of analysis. This is one of them. CONTEXT: A MASS-PARTICIPATION RACE, NOT AN ELITE ARENA The Portland Marathon is one of America's long-established, heavily attended mass-participation road races. Let me be clear from the outset: this is not an elite arena. There is no selection quota, no qualifying standard, no world ranking. People register, pay a fee, and run. The event belongs to the "mass-participation" category — one that anyone self-declaring adequate health can enter. For that reason, my usual analytical framework — performance, head-to-head rivalry, qualifying standards — simply does not apply. No finish time, no average pace, and no 5 km split markers for the victim have been released. The detail "collapsed at mile 20" is a spatial marker, not a performance marker. Any attempt to infer his fitness or pace is baseless speculation. For a recreational runner there is no "personal best" in the competitive sense, no form-development curve, no recovery index. The columns I normally use to assess a professional athlete are empty here — and that emptiness is itself a data point. What remains to be analyzed, then, is not the course. It is the medical system, the screening mechanism, and the gap between a sport's popularity and its capacity to protect the people who play it. The organizer is identified as Motiv Sports, with executive director Crystian Kumnick speaking on its behalf. It confirmed a medical emergency occurred but declined to give athlete-specific detail — a standard posture on privacy and liability. The community responded with a GoFundMe campaign that raised about $60,000. Those three facts — a death, an organizer's silence, a community fundraiser — paint the portrait of the entire mass-marathon ecosystem. And within that portrait, the central question is not "how fast did he run" but "did anyone ever look at his heart." One more detail deserves verification. The source records the incident as "4/10." If that means October 4, it fits the Portland Marathon's traditional fall schedule. If it means April 10, the environmental profile — temperature, humidity — would differ materially, and that could change how the whole case reads. This is a detail requiring independent confirmation, and I raise it so the reader knows that serious analysis begins by admitting what it cannot be sure of. CORE: AGE, MECHANISM, AND WHAT IS CLAIMED WITHOUT BEING PROVEN I never issue a judgment without looking at the numbers. Even when my gut says otherwise. But here, the most important number is not on a stopwatch. It is on a health-screening report — a document that, by every indication, does not exist. Age is the single most analytically significant variable. At 25, a person collapsing from cardiac arrest during a marathon falls into the demographic where cardiovascular death is usually tied to structural or electrical abnormalities of the heart, not to atherosclerotic coronary disease — the dominant culprit in older runners. This is a decisive distinction that much popular reporting overlooks. More specifically: hypertrophic cardiomyopathy is a leading cause of sudden death in young athletes. Alongside it are congenital coronary anomalies and ion-channel disorders — long-QT syndrome, CPVT, Brugada — conditions that can cause fatal arrhythmias without leaving any structural trace on cardiac imaging. All three groups share one lethal trait: they stay silent until the first fatal event. Routine physicals do not detect them. This is why the family's assertion — "completely healthy, no underlying disease" — must be read for what it is. It is testimony from relatives, not medical evidence. The original article itself carefully notes this: no medical conclusion has ruled out a hidden abnormality. That caution deserves credit — it is an editorial guardrail against premature causal attribution, something sports journalism often handles very badly. One technical detail the original article includes carries great analytical weight: the American Heart Association distinguishes clearly between "cardiac arrest" and "myocardial infarction." A myocardial infarction is a heart attack caused by blocked blood flow to the heart muscle. Cardiac arrest is a sudden loss of heart function, usually from an electrical rhythm disturbance, in which the heart stops pumping blood. The two can be linked but differ in nature. The article's use of the AHA definition suggests the mechanism considered leans toward an electrical or rhythm event — which pushes the case toward rhythm disorders and structural anomalies in the young. Two further possibilities the source does not raise deserve a place at the table because they bear directly on young marathoners. The first is exercise-associated hyponatremia — dangerously low blood sodium from drinking too much water during long-distance running, which can cause collapse and cardiac arrest. The second is undiagnosed myocarditis, often post-viral, and one of the leading causes of sudden death in young adults. These are legitimate analytical flags, not accusations. A 25-year-old who trained for months may have carried a heart that had weathered a silent inflammation no one knew about. In other words: in a case like this, the unknown outweighs the known. And anyone rushing to a conclusion — in either direction — is doing what the data does not permit. People want a tidy answer, a single cause. Biology is rarely that tidy. THE SCREENING GAP: NOBODY'S PROBLEM, AND EVERYBODY'S The crux of this story is not the individual Trey Lara. It is a systemic gap. In the United States, entering a mass-participation marathon requires no cardiac screening whatsoever. No mandatory electrocardiogram (ECG), no mandatory echocardiogram, no mandatory stress test. Participants self-declare their health, sign a liability waiver, and run. This is a systemic reality, not one person's fault. A comparison makes the problem clear. A professional athlete — with a medical team, a sports physician, and a regular screening schedule — is generally checked far more often. The recreational runner, by contrast, has almost no protective layer. That is the paradox: the largest, most diverse, and least-screened group is also the group most exposed in certain scenarios. When I followed women's track events in Vietnam, I saw the same thing on a smaller scale: young athletes training without access to regular cardiac checks, and nobody treating it as a problem until someone collapsed. One contextual figure (pending verification, not in the original source) puts the rate of sudden cardiac death in marathon running at roughly 0.5 to 1 per 100,000 participants. The number sounds small. But as global marathon participation climbs into the millions each year, and as the ranks of first-time runners — with less pacing discipline and less familiarity with the physiological strain of 42.195 km — swell, the absolute number is no longer small. A small rate multiplied by a huge population yields a not-small toll. I have said that data does not discriminate by gender; only prejudice does. The same holds here: the screening gap does not distinguish male from female runners, newcomers from veterans. It distinguishes only between those with access to sports medicine and those without. And the troubling part is that those without are usually the majority. MILE 20: WHY THERE There is a physiological logic behind mile 20 — roughly two miles after the exchange at mile 18. In a marathon, the final third is when cumulative strain on the cardiovascular and thermoregulatory systems peaks. The runner has burned most glycogen reserves, core temperature has risen, heart rate has stayed in a high zone for hours, and the body endures prolonged stress. This is the zone where acute cardiac events are most probable. That the event occurred at mile 20, not at mile 5 or mile 40, matches a physiological pattern sports medicine has long known. Notably, no split data was released. We do not know how the runner paced the first 20 miles, whether he accelerated, or whether he showed signs of fading beforehand. With split data, we could assess whether a pace-related or effort-related trigger preceded the event. Without it, any inference about the precipitating cause lacks foundation. Once again: the data gap is itself a finding. WHAT THE ARTICLE DOES NOT SAY Some questions the source leaves open, and leaving them open is part of the story. First, was an automated external defibrillator (AED) deployed in time? Response time is decisive in surviving out-of-hospital cardiac arrest. The source does not say. One cannot infer either adequacy or negligence from silence. Second, what was the density of medical stations and the spacing between them on the course? Unclear. This is a question every race organizer should answer before the next season begins. Third, did the runner ever undergo any advanced cardiac screening? Almost certainly not, since it is not a mandatory procedure — but this is inference, not fact. Raising these gaps is not about doubting anyone. It is the only way an analysis stays honest with the data. The remark ignored in one year becomes a lesson for the next generation — and here, the ignored remark is the question of screening, one the mass-running industry has heard many times but never answered decisively. CONTRARIAN: COMMERCIAL VALUE AND SAFETY VALUE DO NOT RUN IN PARALLEL This is where I want to state plainly something the mass-sport industry tends to avoid. Mass-participation marathons have become a colossal industry. Races spring up everywhere, draw millions, and generate revenue from fees, sponsorship, equipment, and sports tourism. They sell you the dream of conquering 42.195 km. They sell you a jersey, shoes, a heart-rate watch, and a medal. But there is one thing they do not sell alongside it: the assurance that your heart is safe enough to run. A mass marathon's commercial value is proportional to its participant numbers. Its safety value should, in principle, be proportional to its medical capacity and screening — but those two lines do not run in parallel. This is the strategic blind spot of the entire ecosystem. Organizers invest in marketing to grow registrations, but investment in cardiac screening has not kept pace with that growth. When a case like Trey Lara's happens, the system does not collapse, but it reveals a crack. And that crack is not Portland's alone. It is the crack of every city with a crowded marathon and a thin screening process. I remember a line I once wrote: "When the stands are empty, I hear my own echo more clearly." Here, when the cheering along the course falls silent, what remains is the question: are we selling the dream of sport without selling safety alongside it? And one more thing: women's marathons, less funded and less covered, often have thinner medical density. If the screening gap is already a problem at big races, then at small ones — with tight budgets and scant attention — it is more serious still. When we talk about equality in sport, we usually talk about prize money and broadcast slots. We rarely talk about defibrillators and medical stations. But real equality begins with being protected equally. TAKEAWAY Trey Lara did not die because he ran a marathon. He died because of a heart no one had ever examined closely enough before he stepped onto the course. That difference is not small. This story should not end with a summary of running's risks. It should end with a question aimed at the future: what will change in how mass marathons screen and protect their participants? The running industry can choose to keep the status quo and let community fundraising clean up after each incident. Or it can choose to treat every registration as a promise of safety, not just of experience. The change is already happening — slowly, but for real. The only question is whether it arrives before or after the next case.